Spiga

ARTICLES Carbohydrate Sources Mi So Many People in Indonesia


In addition to rice, there are many people in Indonesia got the carbohydrate source of noodle consumption. Individual Food Consumption Survey (SKMI) 2014, a source of carbohydrates of noodles as many as 32.6 grams per person per day. Most are of rice about 197.1 grams per person per day.

Meanwhile, the rest is from refined flour (9.6 g), wheat (9.4 grams), processed rice (4.2 grams), and corn and dairy (4.1 grams).

Results SKMI 2014 submitted by the Head of Applied Technology Center Health and Clinical Epidemiology Parade Siswanto in Health Research in Building Ministry of Health, Jakarta, Monday (12/29/2014).

"Consumption of food as a source of carbohydrates are mostly from cereals (257.7 grams) and tubers (27.1 grams). In the group of cereals, rice consumption is highest, followed noodles, "said Siswanto.

Siswanto explained, the survey was conducted in 497 districts / cities of 34 provinces in Indonesia. Samples were taken from 46 238 households and retrieved the data for analysis as much as 45 802 households.

The members of the household (ART) who were interviewed and made as much as 145 360 ART analysis. Respondents consisted of men and women of various ages. Survey method is to interview the 24-hour food intake.

The survey also looked at the source of protein obtained society. For a source of protein, most people get from fish (78.4 grams), nuts (56.7 grams), meat (42.8 grams), eggs (19.7 grams), and milk (6.4 grams) .

The survey also shows the nutritional adequacy of the community in Indonesia. As a result, the province where people are less calories and protein is moderately high in East Nusa Tenggara, Papua, and Lampung. Meanwhile, the province most people enough calories and protein, namely, Riau Islands, Pacific Islands, and Jakarta.

Looking at the results of this survey, Siswanto said the need to strengthen the program of balanced nutrition. Additionally, penganekragaman food, especially the empowerment of local food also needs to be improved.

"Looking at the nutritional adequacy, both calories and protein, the government needs to increase back food security and nutrition programs. On the other hand, also need penyulusan related to excess calorie intake to prevent obesity, a risk factor for degenerative diseases, "said Siswanto.

Siswanto also asking the public to ensure the consumption of healthy and nutritious foods.

Herbal Medicine Herbal medicine is hoped So Identity Indonesia


Utilization of herbal ingredients locally as a treatment in the traditional way, or which is known as herbal medicine has been done a long time in this country. Therefore, herbal medicine is expected to be the identity of Indonesian herbal medicine.

"Herb is a native Indonesian culture, so the development of herbal medicine was supposed to be still uses the term herbal medicine," said Dr. Arijanto Jonosewojo, herbal medicine expert from the Faculty of Medicine, University of Airlangga, Thursday (08/22/2013) in Jakarta.

The development of herbal medicines made from all over the world allows people to use it into the type of treatment that is efficacious and safe. So according Arijanto, herbal medicine in Indonesia needs to have an identity.

Arijanto mention, herbal medicine is currently divided into three groups, namely herbs, standardized herbal medicine (OHT), and fitofarmaka. "In the future expected his name to OHT or medicinal herbs phytopharmaca," he said.

To get there, he said, needed saintifikasi or verification process safety and efficacy of herbs for health scientifically. By doing so, herbs can be used as a trusted physician treatment.

"So far, most of the herbal ingredients used for traditional herbal medicine then departed from the empirical evidence, not scientific. So it has not been able to be trusted," he explained.

Nevertheless, the process is not easy saintifikasi. It takes quite a long time to declare a formulation proven to be safe and efficacious. Saintifikasi process includes standardized testing, toxicity in experimental animals, preclinical testing and clinical trials.